|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
EBOOKCENTRAL_ocn993066575 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
170708s2016 xx o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d MERUC
|d OCLCQ
|d YDX
|d EBLCP
|d AU@
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d UKAHL
|d LOA
|d OCLCO
|d OCLCF
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 992788997
|
| 020 |
|
|
|a 9781937585594
|
| 020 |
|
|
|a 193758559X
|
| 029 |
1 |
|
|a AU@
|b 000068464226
|
| 035 |
|
|
|a (OCoLC)993066575
|z (OCoLC)992788997
|
| 050 |
|
4 |
|a RM324.8
|b .S47 2016
|
| 060 |
|
4 |
|a QV 77.7
|
| 082 |
0 |
4 |
|a 615.7/883
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Sessa, Ben.
|
| 245 |
1 |
0 |
|a Psychedelic Drug Treatments :
|b Assisting the Therapeutic Process.
|
| 260 |
|
|
|a Bloomfield :
|b Mercury Learning & Information,
|c 2016.
|
| 300 |
|
|
|a 1 online resource (154 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a MyModernHealth FAQs Ser.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Half Title Page; Title Page; Copyright Page; Contents; Preface; Acknowledgments; PART ONE An Introduction to Psychotropic and Psychedelic Drugs; CHAPTER 1 Psychoactive Compounds; 1. What are psychoactive drugs?; 2. How are psychotropic drugs different from psychoactive drugs?; 3. What are psychotherapeutic drugs?; 4. How are psychopharmaceuticals distinguished from the other "psychos"?; 5. What are some psychotherapeutic medications and what disorders do they treat?; 6. How long have these medicines been used therapeutically?; 7. What are designer drugs?; CHAPTER 2 Psychedelic Compounds.
|
| 505 |
8 |
|
|a 8. What are psychedelic drugs?9. How are psychedelics different from other hallucinogens?; 10. What does "psychedelic" mean?; 11. What do these alternative terms mean?; 12. What are the various psychedelic compounds?; 13. What are the effects of the tryptamine-based psychedelics?; 14. What are the tryptamine psychedelics?; 15. What are the effects of the phenethylamine-based psychedelics?; 16. What are the phenethylamine psychedelics?; CHAPTER 3 A Bit About the Brain; 17. How does the brain work?; 18. How do the neurons connect to each other?; 19. What are neurotransmitters?
|
| 505 |
8 |
|
|a 20. What are agonists and antagonists?21. What are endogenous and exogenous substances?; 22. What is the importance of serotonin?; 23. What is an entheogen?; 24. Are all psychedelic drugs entheogens?; 25. What are entactogens or empathogens?; CHAPTER 4 How Do Psychoactive Medications Work in the Brain?; 26. How important are the neurotransmitters?; 27. How do psychoactive chemicals interact with the neurotransmitters?; 28. How do psychedelics work in the brain?; 29. Why are psychedelics not being used as medicines?; PART TWO A Brief History of Research Efforts.
|
| 505 |
8 |
|
|a CHAPTER 5 A Brief History: From Ages Past to Research in the Early 20th Century30. When were psychedelics first discovered?; 31. Were these plants and fungi used only in ceremonies?; 32. When did psychedelics first come to the attention of the scientific community?; 33. Who performed some of this earliest research and what did it entail?; 34. When was LSD discovered?; 35. Is it true that Hofmann's discovery of LSD was accidental?; 36. When did LSD become available for use in psychotherapy?; CHAPTER 6 Psychedelic Research and Pioneers in the mid-1900s.
|
| 505 |
8 |
|
|a 37. Were psychedelics being used to treat mental illnesses at this time?38. What was the MK-Ultra program?; 39. Who were some of the notable clinicians and researchers in the early part of this era?; 40. What was Dr. Humphry Osmond's major contribution to the field?; 41. Why was Aldous Huxley's involvement with psychedelics significant?; 42. When did Huxley first try LSD?; 43. Why was Alfred Hubbard called "Captain Trips"?; 44. What research efforts were going on in the UK?; 45. Were psychedelics being used in Europe?; 46. Did Timothy Leary make any valid contribution in terms of research?
|
| 500 |
|
|
|a 47. How did Leary become involved with psychedelics?
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Hallucinogenic drugs
|x Therapeutic use.
|
| 650 |
|
0 |
|a Hallucinogenic drugs
|x History.
|
| 650 |
|
2 |
|a Hallucinogens
|x therapeutic use
|
| 650 |
|
6 |
|a Hallucinogènes
|x Emploi en thérapeutique.
|
| 650 |
|
6 |
|a Hallucinogènes
|x Histoire.
|
| 650 |
|
7 |
|a Hallucinogenic drugs
|2 fast
|
| 650 |
|
7 |
|a Hallucinogenic drugs
|x Therapeutic use
|2 fast
|
| 655 |
|
7 |
|a History
|2 fast
|
| 700 |
1 |
|
|a Worthey, Eileen.
|
| 758 |
|
|
|i has work:
|a Psychedelic drug treatments (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFXcJ3Q8DDx4PtCKp4gGBP
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Sessa, Ben.
|t Psychedelic Drug Treatments : Assisting the Therapeutic Process.
|d Bloomfield : Mercury Learning & Information, ©2016
|
| 830 |
|
0 |
|a MyModernHealth FAQs Ser.
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4895051
|z Texto completo
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH33355044
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH34715551
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL4895051
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 15361205
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 14669002
|
| 994 |
|
|
|a 92
|b IZTAP
|
